3,674
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database

, , , , , & show all
Pages 435-443 | Received 10 May 2017, Accepted 03 Aug 2017, Published online: 07 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Atsushi Ogata, Yasuhiro Kato, Shinji Higa & Kazuyuki Yoshizaki. (2019) IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. Modern Rheumatology 29:2, pages 258-267.
Read now

Articles from other publishers (4)

Alfredo Madrid-García, Beatriz Merino-Barbancho, Alejandro Rodríguez-González, Benjamín Fernández-Gutiérrez, Luis Rodríguez-Rodríguez & Ernestina Menasalvas-Ruiz. (2023) Understanding the role and adoption of artificial intelligence techniques in rheumatology research: An in-depth review of the literature. Seminars in Arthritis and Rheumatism 61, pages 152213.
Crossref
Mark Berman, Ronen Ben-Ami, Shlomo Berliner, Marina Anouk, Ilana Kaufman, Adi Broyde, Sara Borok & Ori Elkayam. (2021) The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature. Life 11:3, pages 258.
Crossref
Sandra Rodríguez, Andrés Muñoz, Rosa-Helena Bustos & Diego Jaimes. (2020) Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 8:9, pages 303.
Crossref
David Armstrong, Alex Dregan, Mark Ashworth, Patrick White, Chris McGee & Simon de Lusignan. (2020) Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice. Rheumatology 59:6, pages 1281-1287.
Crossref